Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 May;33(5):188-92.
doi: 10.3109/07357907.2015.1019679. Epub 2015 Apr 1.

Cyberknife treatment for low and intermediate risk prostate cancer

B Detti  1 , P Bonomo, L Masi, R Doro, S Cipressi, C Iermano, I Bonucci, D Franceschini, V Di Cataldo, L Di Brina, M Baki, G Simontacchi, I Meattini, M Carini, S Serni, G Nicita, L Livi
Affiliations

Cyberknife treatment for low and intermediate risk prostate cancer

B Detti et al. Cancer Invest. 2015 May.

Abstract

Cyberknife is an emerging treatment for early stage prostate cancer. Between October 2012 and January 2014, 32 patients were treated in our institution. Prescribed dose was 35-36.25 Gy in five fractions. Biochemical response was observed in 22 patients. Four patients experienced G2 acute genitourinary toxicity and in two cases we recorded G3 acute GU toxicity. 5 patients experienced G2 acute proctitis. At last follow up visit, all patients were still alive. 29 remained free of disease at last follow up appointment, while three developed a biochemical recurrence. Our experience confirms the efficacy and safety of Cyberknife for localized prostate cancer.

Keywords: Cyberknife; Prostate cancer; Radiation oncology.

PubMed Disclaimer

LinkOut - more resources